sinc
discoveri
proteinas
enzym
probabl
becom
bestcharacter
peptidas
sever
hundr
crystal
structur
inhibitor
complex
determin
date
howev
main
proteinas
sar
coronaviru
pro
also
call
pro
good
chanc
catch
first
threedimension
structur
coronaviru
pro
publish
enzym
transmiss
gastroenter
viru
tgev
interest
coronavirida
moder
sinc
virus
consid
rel
harmless
human
health
assess
chang
dramat
late
march
found
ongo
global
outbreak
highli
infecti
sever
acut
respiratori
syndrom
caus
new
coronaviru
subsequ
name
sarscov
sinc
effort
discov
antisar
drug
numer
order
prepar
viru
rais
ugli
head
coronaviru
genom
code
two
larg
polyprotein
process
viral
proteinas
yield
individu
compon
larg
replicas
complex
coronavirus
three
cystein
proteinas
respons
process
two
papainlik
proteinas
main
proteinas
pro
interestingli
one
two
papainlik
proteinas
absent
sar
coronaviru
one
shown
addit
function
deubiquitin
enzym
papainlik
proteinas
togeth
respons
three
cleavag
reaction
near
n
terminu
polyprotein
pro
cleav
huge
substrat
molecular
mass
kda
less
site
sinc
reaction
essenti
viral
replic
main
proteinas
obvious
prime
target
interfer
inhibitor
first
step
toward
inhibitor
design
coronaviru
pro
crystal
structur
elucid
complex
tgev
enzym
hexapeptidyl
chloromethyl
keton
inhibitor
amino
acid
sequenc
correspond
specif
enzym
mode
bind
inhibitor
target
enzym
found
relat
although
ident
seen
earlier
complex
rhinoviru
proteinas
compound
figur
vinylog
ethyl
ester
develop
agouron
inc
divis
pfizer
treatment
common
cold
caus
rhinovirus
observ
led
propos
good
start
point
design
antisar
inhibitor
crystal
structur
main
proteinas
human
coronaviru
sar
viru
solv
within
week
identif
new
viru
structur
insight
along
inform
flexibl
enzym
enabl
research
worldwid
use
structurebas
design
virtual
screen
method
prepar
new
inhibitor
sarscov
pro
sever
deriv
figur
describ
much
activ
parent
compound
display
low
toxic
cell
assay
origin
sar
patient
hong
kong
toronto
treat
ribavirin
surfac
compound
effici
viru
least
nontox
concentr
hiv
proteinas
inhibitor
test
preclin
surprisingli
inhibit
sarscov
main
proteinas
vitro
cell
cultur
thu
wong
cowork
found
lopinavir
figur
inhibit
pro
ic
mm
new
contribut
group
present
issu
origin
attempt
improv
inhibitori
properti
lopinavir
author
assembl
librari
lopinavirlik
compound
coupl
amin
variou
acid
microtit
plate
follow
screen
situ
n
n
n
ntetramethyluronium
hexafluorophosph
hbtu
use
coupl
reagent
sever
lopinavir
deriv
show
somewhat
improv
bind
affin
came
big
surpris
intermedi
benzotriazol
ester
result
activ
acid
compon
hbtu
nanomolar
inhibitor
pro
thu
remark
case
reaction
intermedi
highli
activ
inhibitor
target
enzym
next
author
synthes
seri
benzotriazol
ester
figur
condens
hbtu
variou
aromat
carboxyl
acid
found
compound
carri
electrondon
substitu
strong
irrevers
inhibitor
pro
k
nm
best
deriv
use
mass
spectrometri
wu
et
al
show
compound
act
acyl
catalyt
cystein
residu
pro
also
demonstr
benzotriazol
deriv
nontox
vero
cell
standard
cell
use
antisarscov
assay
concentr
mm
yet
clear
inhibitor
quit
far
drug
useabl
treat
coronaviru
infect
sar
mode
action
seem
like
inhibit
cellular
cystein
proteinas
well
viral
one
howev
acyl
compound
could
potenti
modifi
substitu
occupi
specif
pocket
enzym
therefor
use
start
point
design
specif
inhibitor
reactiv
specif
often
counteract
would
desir
inhibitor
sarscov
main
proteinas
coval
modifi
catalyt
cystein
residu
paper
wu
et
al
also
describ
benzotriazol
ester
surrog
ester
oxygen
replac
methylen
group
thu
suscept
nucleophil
attack
activ
site
cystein
compound
see
scheme
wu
et
al
competit
inhibitor
k
valu
lower
micromolar
rang
thu
among
potent
noncoval
inhibitor
sarscov
pro
describ
date
discoveri
compound
bind
noncoval
pro
may
end
constitut
import
mileston
way
clinic
use
inhibitor
coronaviru
main
proteinas
identif
acyl
agent
